Federation des caisses Desjardins du Quebec »

Summit Therapeutics shares owned by Federation des caisses Desjardins du Quebec

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Federation des caisses Desjardins du Quebec from 13F filings

Historical chart of Federation des caisses Desjardins du Quebec investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Federation des caisses Desjardins du Quebec consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Federation des caisses Desjardins du Quebec

Quarter filed Position value Share count Share price at filing
2025-09-30 $192k 9.3k 20.66

More positions owned by Federation des caisses Desjardins du Quebec

Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Apple (AAPL)
Bk Nova Cad (BNS)
Cgi Cl A Sub Vtg (GIB)
Amazon (AMZN)
Tc Energy Corp (TRP)
Bank Of Montreal Cadcom (BMO)
Canadian Pacific Kansas City (CP)
Cibc Cad (CM)
Enbridge (ENB)
Telus Ord (TU)

View all positions for Federation des caisses Desjardins du Quebec

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Susquehanna International
Geode Capital Management
Citadel Advisors
Pictet Asset Management Holding SA
Norges Bank Investment Management
Apeiron Capital
Nomura Holdings
TD Asset Management
Standard Life Aberdeen
Charles Schwab Investment Management

View all funds holding Summit Therapeutics